General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
13K |
5.1M |
19 |
30/07/25 |
30/07/25 |
General
|
13K
|
5.1M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Upcoming 2025 Investor Events
|
|
RaceOncology
|
56 |
17K |
11 |
30/07/25 |
30/07/25 |
ASX - By Stock
|
56
|
17K
|
11
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
13K |
5.1M |
40 |
29/07/25 |
29/07/25 |
General
|
13K
|
5.1M
|
40
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
13K |
5.1M |
38 |
29/07/25 |
29/07/25 |
General
|
13K
|
5.1M
|
38
|
|
ASX - By Stock
|
RAC |
Re:
I'm keen to understand
|
|
RaceOncology
|
101 |
28K |
58 |
29/07/25 |
29/07/25 |
ASX - By Stock
|
101
|
28K
|
58
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
13K |
5.1M |
34 |
28/07/25 |
28/07/25 |
General
|
13K
|
5.1M
|
34
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
13K |
5.1M |
24 |
28/07/25 |
28/07/25 |
General
|
13K
|
5.1M
|
24
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
13K |
5.1M |
76 |
28/07/25 |
28/07/25 |
General
|
13K
|
5.1M
|
76
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification regarding unquoted securities - RAC
|
|
RaceOncology
|
12 |
3.8K |
7 |
25/07/25 |
25/07/25 |
ASX - By Stock
|
12
|
3.8K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification regarding unquoted securities - RAC
|
|
RaceOncology
|
12 |
3.8K |
14 |
25/07/25 |
25/07/25 |
ASX - By Stock
|
12
|
3.8K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
38 |
24/07/25 |
24/07/25 |
ASX - By Stock
|
136
|
36K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
22 |
24/07/25 |
24/07/25 |
ASX - By Stock
|
136
|
36K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
24 |
24/07/25 |
24/07/25 |
ASX - By Stock
|
136
|
36K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification regarding unquoted securities - RAC
|
|
RaceOncology
|
12 |
3.8K |
64 |
24/07/25 |
24/07/25 |
ASX - By Stock
|
12
|
3.8K
|
64
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
10 |
24/07/25 |
24/07/25 |
ASX - By Stock
|
136
|
36K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
40 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
38 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
42 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
45 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
45 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
52 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
52
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
44 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
34 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
24 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
24 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
RaceOncology
|
136 |
36K |
128 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
128
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
13K |
5.1M |
68 |
18/07/25 |
18/07/25 |
General
|
13K
|
5.1M
|
68
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
13K |
5.1M |
45 |
18/07/25 |
18/07/25 |
General
|
13K
|
5.1M
|
45
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
13K |
5.1M |
22 |
18/07/25 |
18/07/25 |
General
|
13K
|
5.1M
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
RaceOncology
|
474 |
182K |
16 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
474
|
182K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
38 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
262
|
76K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
RaceOncology
|
474 |
182K |
7 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
474
|
182K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Upcoming 2025 Investor Events
|
|
RaceOncology
|
56 |
17K |
7 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
56
|
17K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
13K |
5.1M |
61 |
17/07/25 |
17/07/25 |
General
|
13K
|
5.1M
|
61
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
23 |
16/07/25 |
16/07/25 |
ASX - By Stock
|
262
|
76K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
3 |
16/07/25 |
16/07/25 |
ASX - By Stock
|
262
|
76K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Upcoming 2025 Investor Events
|
|
RaceOncology
|
56 |
17K |
9 |
16/07/25 |
16/07/25 |
ASX - By Stock
|
56
|
17K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Upcoming 2025 Investor Events
|
|
RaceOncology
|
56 |
17K |
39 |
15/07/25 |
15/07/25 |
ASX - By Stock
|
56
|
17K
|
39
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Upcoming 2025 Investor Events
|
|
RaceOncology
|
56 |
17K |
34 |
15/07/25 |
15/07/25 |
ASX - By Stock
|
56
|
17K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Upcoming 2025 Investor Events
|
|
RaceOncology
|
56 |
17K |
4 |
15/07/25 |
15/07/25 |
ASX - By Stock
|
56
|
17K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
17 |
14/07/25 |
14/07/25 |
ASX - By Stock
|
262
|
76K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
RaceOncology
|
3.1K |
1.1M |
4 |
14/07/25 |
14/07/25 |
ASX - By Stock
|
3.1K
|
1.1M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
23 |
14/07/25 |
14/07/25 |
ASX - By Stock
|
262
|
76K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
6 |
14/07/25 |
14/07/25 |
ASX - By Stock
|
262
|
76K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
4 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
28 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
48 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
48
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
9 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
47 |
10/07/25 |
10/07/25 |
ASX - By Stock
|
262
|
76K
|
47
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
RaceOncology
|
262 |
76K |
24 |
10/07/25 |
10/07/25 |
ASX - By Stock
|
262
|
76K
|
24
|
|